Novartis Pharmaceuticals Corporation: Diovan (valsartan) 160 Mg, 90 Tablets
Diovan Recall Summary Novartis is recalling Diovan (valsartan) 160 mg tablets in 90-tablet bottles because they failed to meet dissolution specifications, meaning the tablets may not break down properly in the body. The recalled product was manufactured by Patheon Manufacturing Services LLC and distributed nationwide across all U.S. states and Washington, D.C. This is a Class II recall, indicating the product could cause adverse health effects.
- Recalling firm
- Novartis Pharmaceuticals Corporation
- Product
- Diovan (valsartan) 160 mg, 90 tablets, Rx only, Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834, Distributed by: Novartis Pharmaceutical Corp, East Hanover, NJ 07936, NDC 0078-0359-34
- Reason
- Failed Dissolution Specifications
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-08-04
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- US Nationwide
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/6cdfd6f5-a8d4-44c3-8ace-65b9a2335cd5